Eric Miller, MD, PhD, of The Ohio State University Medical Center (IMAGE)
Caption
Alliance A022101: Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Led by Eric Miller, MD, PhD, of The Ohio State University Medical Center, the ERASur trial is enrolling patients with colorectal cancer that has spread beyond the liver. This phase III study tests whether adding total ablative therapy (in the form of stereotactic radiation therapy, surgery, and microwave ablation treatment) to the usual chemotherapy improves survival for this group of patients.
Credit
The Ohio State University Medical Center
Usage Restrictions
none
License
Original content